Related Experiment Video
Updated: Feb 22, 2026

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
Pediatric renal cell carcinomas with Xp11.2 rearrangements are immunoreactive for hMLH1 and hMSH2 proteins
Dinesh Rakheja1, Payal Kapur, Gail E Tomlinson
1Department of Pathology, Children's Medical Center and University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. dinesh.rakheja@utsouthwestern.edu
Abstract:
Alveolar soft part sarcoma and pediatric renal cell carcinoma share a similar chromosomal abnormality, t(X;17)(p11.2;q25). Recently, it has been suggested that the inactivation of DNA mismatch repair genes hMLH1 and hMSH2 may play an additional role in the pathogenesis of alveolar soft part sarcoma. Immunohistochemical expression of the proteins hMLH1 and hMSH2 is indicative of the activation status of the corresponding genes. We performed immunohistochemistry for hMLH1 and hMSH2 in 4 cases of pediatric renal cell carcinomas with Xp11.2 rearrangements. All cases showed nuclear immunoreactivity for both proteins, although the staining was patchy. Our study demonstrates that inactivation of the DNA mismatch repair genes hMLH1 and hMSH2 does not appear to play a role in the tumorigenesis of pediatric renal cell carcinomas with Xp11.2 rearrangements.
Insights
In pediatric renal cell carcinoma with Xp11.2 rearrangements, DNA mismatch repair genes hMLH1 and hMSH2 remain active. This study found no evidence that their inactivation contributes to tumor development in these specific pediatric kidney cancers.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Alveolar soft part sarcoma (ASPS) and pediatric renal cell carcinoma (pRCC) share the t(X;17)(p11.2;q25) chromosomal abnormality.
- Inactivation of DNA mismatch repair genes (hMLH1, hMSH2) has been implicated in ASPS pathogenesis.
- The role of these genes in pRCC with Xp11.2 rearrangements is not fully understood.
Purpose of the Study:
- To investigate the status of DNA mismatch repair genes hMLH1 and hMSH2 in pediatric renal cell carcinomas with Xp11.2 rearrangements.
- To determine if the inactivation of hMLH1 and hMSH2 plays a role in the tumorigenesis of these specific pRCC cases.
Main Methods:
- Immunohistochemistry was used to assess the expression of hMLH1 and hMSH2 proteins.
- The study analyzed 4 cases of pediatric renal cell carcinoma exhibiting Xp11.2 rearrangements.
Main Results:
- All analyzed pediatric renal cell carcinoma cases demonstrated nuclear immunoreactivity for both hMLH1 and hMSH2 proteins.
- The observed staining for hMLH1 and hMSH2 was patchy, indicating retained protein expression.
Conclusions:
- Inactivation of DNA mismatch repair genes hMLH1 and hMSH2 does not appear to be involved in the development of pediatric renal cell carcinomas with Xp11.2 rearrangements.
- The findings suggest that alternative molecular pathways are likely responsible for tumorigenesis in this specific subtype of pRCC.
Related Concept Videos
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

